---
name: Full paper review v1
description: Comprehensive NeurIPS 2026 review of complete paper (Sections 1-4 + 3.6 convergence + Appendix A). Score 4.5/10.
type: project
---

# Full Paper Review v1 (2026-04-17)

**Score: 4.5/10 (borderline weak reject)**

## Key Verdict
- Core insight (decoupled monitoring enables boosting) is genuine and novel
- Empirical evidence: clear improvement only on CREMA-D (+2.31pp over OGM-GE)
- Boost-only barely helps on CREMA-D (+1.13pp) -- method depends on OGM-GE
- 7/8 datasets: gains <1pp or within noise, no significance tests
- MOSEI: boost-only HURTS baseline (-0.62pp). Boost+OGM-GE on Sarcasm below baseline (-0.64pp)
- Convergence theory (Props 1-3): correct but trivial (standard SGD + bounded scaling)
- Paper structurally incomplete: no abstract, no discussion/conclusion, checklist all TODO

## Critical Issues Ranked
1. Method is a wrapper around OGM-GE (MAJOR)
2. "Never hurts" claim contradicted by data (MODERATE-MAJOR)
3. Convergence analysis provides no insight beyond "doesn't break SGD" (MODERATE)
4. Structurally incomplete (MAJOR for submission)
5. No statistical significance tests (MODERATE)
6. Missing ablation: unimodal regularization confound (MODERATE)
7. Two alpha values (0.5 vs 0.75) undermine "fixed hyperparameters" claim (MINOR-MODERATE)

## Path to Accept (5.5-6.5)
1. Additional high-imbalance benchmarks where boost-only works
2. Proper statistical tests + honest categorization of results
3. Abstract + discussion + limitations + checklist
4. Unimodal reg ablation (gamma=0 vs gamma=1)
5. Theory upgrade or honest framing as sanity checks

**Why:** Comprehensive assessment to guide final revision strategy.
**How to apply:** Reference for all future revision advice. Previous section reviews are now superseded by this holistic assessment.
